MedTrace Logo

Cardiac Rehabilitation for the Treatment of Refractory Angina

NCT00411359 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2015-04-22

No results posted yet for this study

Summary

The purpose of this study is to determine whether cardiac rehabilitation is a successful treatment for refractory angina, in relation to improvements in cardiovascular risk factors, physical ability, symptomology, quality of life and psychological morbidity.

Conditions

  • Angina Pectoris
  • Coronary Disease

Interventions

BEHAVIORAL

Cardiac rehabilitation

Phase III cardiac rehabilitation programme

Sponsors & Collaborators

  • British Heart Foundation

    collaborator OTHER

  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER

  • National Heart and Lung Institute

    lead OTHER

Principal Investigators

  • Peter Collins, MA, MD, FRCP · National Heart and Lung Institute, Imperial College London

  • Kim Fox, MD, FRCP · Royal Brompton & Harefield NHS Foundation Trust

  • Mahmud Barbir, FRCP · Royal Brompton & Harefield NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2009-12-31
Completion
2010-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00411359 on ClinicalTrials.gov